Abstract
Varicella—zoster virus (Herpesvirus varicellae), commonly abbreviated to “V-Z virus” or “VZV,” is the etiologic agent of two diseases of man, varicella and herpes zoster. Varicella (chickenpox) is a ubiquitous, contagious, generalized exanthematous disease of seasonally epidemic propensities that follows primary exposure of a susceptible person, most often a child. Herpes zoster (shingles) is an endemic sporadic disease, most frequent in elderly people, characterized by the appearance of a unilateral, painful, vesicular eruption localized to the dermatome innervated by a specific dorsal root or extra-medullary cranial ganglion. In contrast to varicella, which follows primary exogenous contact with the causative virus, zoster reflects endogenous activation of a VZV infection that has survived in latent form following an attack of varicella. The two clinical entities are not as distinct as is customarily assumed. The patient with zoster frequently develops a disseminated varicelliform eruption; rarely, the person with varicella may exhibit a zosteriform concentration of lesions.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
Alkalay, A. L., Pomerance, J. J., and Rimain, D. L., Fetal varicella syndrome, J. Pediatr. 111: 320–323 (1987).
Antonelli, M. A. S., Moreland, L. W., and Brick, J. E., Herpes zoster in patients with rheumatoid arthritis treated with weekly low-dose methotrexate, Am. J. Med. 90: 295–298 (1991).
Armstrong, R. W., Gurwith, M. J., Waddell, D., and Merigan, T. C., Cutaneous interferon production in patients with Hodgkin’s disease and other cancers infected with varicella or vaccina, N. Engl. J. Med. 283: 1182–1187 (1970).
Armstrong, R. W., and Merigan, T. C., Varicella-zoster virus: Interferon production and comparative interferon sensitivity in human cell cultures, J. Gen. Viral. 12: 53–54 (1971).
Arvin, A. M., Koropchak, C. M., and Wiiek, A. E., Immunologic evidence of reinfection with varicella-zoster virus, J. Infect. Dis. 148: 200–205 (1983).
Arvin, A. M., Pollard, R. B., Rasmussen, L. E., and Merigan, T. C., Selective impairment of lymphocyte reactivity to varicella zoster virus antigen among untreated patients with lymphoma, J. Infect. Dis 137: 531–540 (1978).
Arvin, A. M., Pollard, R. B., Rasmussen, L. E., and Merigan, T. C., Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma, J. Clin. Invest. 65: 869–878 (1980).
Asano, Y., Hiroishi, Y., Itakura, N., Hirose, S., Kajita, Y, Nagal, T., Yazaki, T., and Takahashi, M., Immunoglobulin subclass antibodies to varicella zoster virus, Pediatrics 80: 933–936 (1987).
Asano, Y., Itakura, N., Hiroshi, Y., Hirose, S., Nagai, T., Ozaki, T., Yazaki, T., Yamanishi, K., and Takahashi, M., Viremia is present in incubation period in nonimmunocompromised children with varicella, J. Pediatr. 106: 69–71 (1985).
Asano, Y., Nagai, T., Miyata, T., Yazaki, T., Ito, S., Yamanishi, K., and Takahashi, M., Long-term protective immunity of recipients of the Oka-strain live varicella vaccine, Pediatrics 75: 667–671 (1985).
Baba, K., Yabuuchi, H., Okuni, H., and Takahashi, M., Studies with live varicella vaccine and inactivated skin test antigen; protective effect of vaccine and clinical application of the skin test, Pediatrics 61: 550–555 (1978).
Baba, K., Yabuuchi, H., Takahashi, M., and Ogra, P., Immunologic and epidemiologic aspects of varicella infection acquired during infancy and early childhood, J. Pediatr. 100: 881–885 (1982).
Balfour, H. H., JR., Editorial. Acyclovir therapy for herpes zoster: Advantages and adverse effects, J.A.M.A. 255: 387–388 (1986).
Balfour, H. H., JR., Current management of varicella zoster infections, J. Med. Viral. Suppl. 1: 74–81 (1993).
Barrett, M. J., Hurwitz, E. S., Schonberger, L. B., and Rogers, M. F., Changing epidemiology of Reye syndrome in the United States, Pediatrics 77: 598–602 (1986).
Berger, R., Florent, G., and Just, M., Decrease of the lymphoproliferative response to varicella-zoster antigen in the aged, Infect. Immun. 32: 24–27 (1981).
Berger, R., Luescher, D., and Just, M., Enhancement of varicella-zoster specific immune responses in the elderly by boosting with varicella vaccine, J. Infect. Dis. 149: 647 (1984).
Biron, C. A., Byron, K. S., and Sullivan, J. L., Severe herpes-virus infections in an adolescent without natural killer cells, N. Engl. J. Med. 320: 1731–1735 (1989).
Black, F. L., Hiebholzer, W. J., Pinheiro, F., Evans, A. S., Woodall, J. P., Obton, E. M., Emmons, J. E., West, B. S., Edsall, G., Downs, W. G., and Wallace, G. D., Evidence for persistence of infectious agents in isolated human populations, Am. J. Epidemiol. 100: 230–250 (1974).
Blakely, G. A., Lourie, B., Morton, W. G., Evans, H. H., and Kaufmann, A. F., A varicella-like disease in macaque monkeys, J. Infect. Dis. 127: 617–623 (1973).
Blendon, R. J., The changing epidemiology of Reye’s syndrome in the United States; further evidence for a public health success, J.A.M.A. 260: 3178–3180 (1988).
Bodensteiner, J. B., Hills, M. R., and Riggs, J. E., Clinical features of vascular thrombosis following varicella, Am. J. Dis. Child. 146: 100–102 (1992).
Boggergoren, S., Bernstein, J. M., Gershon, A. A., and Ogra, P. L., Mucosal cell-mediated immunity to varicella-zoster virus: Role in protection against disease, J. Pediatr. 105: 195–199 (1984).
Broussard, R. C., Payne, D. K., and George, R. B., Treatment with acyclovir of varicella pneumonia in pregnancy, Chest 99: 1045–1047 (1991).
Brunell, P. A., Placental transfer of varicella-zoster antibody, Pediatrics 38: 1034–1038 (1966).
Brunell, P. A., Varicella-zoster infections in pregnancy, J.A.M.A. 199: 315–317 (1967).
Brunell, P. A., Gershon, A. A., Uduman, S. A., and Steinberg, S., Varicella-zoster immunoglobulins during varicella, latency, and zoster, J. Infect. Dis. 132: 49–54 (1975).
Brunell, P. A., Ross, A., Miller, L. H., and Kuo, B., Prevention of varicella by zoster immune globulin, N. Engl. J. Med. 280: 1191–1194 (1969).
Buchbinder, S. P., Katz, M. H., Hessol, N. A., Liu, N. A., Liu, J. Y., O’Malley, P. M., Underwood, R., and Holmberg, S. D., Herpes zoster and human immunodeficiency virus infection, J. Infect. Dis. 166: 1154–1156 (1992).
Burke, B. L., Steele, R W., Beard, O. W., WooD, J. S., Cain, T. D., and Marmer, D. J., Immune responses to varicella-zoster in the aged, Arch. Int. Med. 142: 291–293 (1982).
Campbell-Benzie, A., Heath, R. B., Ridehalgh, M. K. S., and Cradockwatson, J. E., A comparison of indirect immunofluorescence and radioimmunoassay for detecting antibody to varicella-zoster virus, J. V irol. Methods 6: 135–140 (1983).
Centers For Disease Control, Zoster immune globulin, Morbid. Mortal. Week. Rep. 25: 211–212 (1976).
Centers For Disease Control, Varicella-zoster immune globulin distribution, 1981–1983. Recommendations of the Immunization Practices Committee on use of immune globulin for the prevention of chickenpox, Morbid. Mortal. Week. Rep. 33: 8190 (1984).
Centers For Disease Control, Annual summary, 1983. Reported morbidity and mortality in the United States, Morbid. Mortal. Week. Rep. 32 (54): 1–125 (1984).
Centers For Disease Control, Summary of notifiable diseases, United States, 1991, Morbid. Mortal. Week. Rep. 40 (53): 164 (1992).
Cheatham, W. J., Weller, T H, Dolan, T. F., and Dower, J. C., Varicella; report of two fatal cases with necropsy, virus isolation, and serologic studies, Am. J. Pathol. 32: 1015–1035 (1956).
Cohrs, R., Mahalingam, R., Dueland, A. N., Wolf, W., Wellish, M., and Gilden, D. H., Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia, J. Infect. Dis. 166 (Suppl. 1): S24–29 (1992).
Colbunders, R., Mann, J. M., Francis, H., Bila, K., Izaley, L., Kakonde, N., Quinn, T. C., Curran, J. W., and Piot, P., Herpes zoster in African patients; a clinical predictor of human immunodeficiency virus infection, J. Infect. Dis. 157: 314–318 (1988).
Collins, S. D., Wheeler, R. E., and Shannon, R. D., The Occurrence of Whooping Cough, Chickenpox, Mumps, Measles, and German Measles in 200,000 Surveyed Families in 28 Large Cities, Special Study Series, No. 1, Division of Public Health Methods, Nih, Usphs, Washington, DC, 1942.
Committee ON Infectious Diseases, American Academy OF Pediatrics, The use of oral acyclovir in otherwise healthy children with varicella, Pediatrics 91: 674–676 (1993).
Cradock-Watson, J. E., Ridehalgh, M. K. S., and Bourne, M. S., Specific immunoglobulin responses after varicella and herpes zoster, J. Hyg. (Comb.) 82: 319–336 (1979).
Demmler, G. J., Steinberg, S. P., Blum, G., and Gershon, A. A., Rapid enzyme-linked immunosorbent assay for detecting antibody to varicella-zoster virus, J. Infect. Dis. 157: 211–212 (1988).
Dlugosch, D., Eis-Hubinger, A. M., Kleim, J. P., Kaiser, R., Bierhoff, E., and Schneweis, K. E., Diagnosis of acute and latent varicella-zoster virus infections using the polymerase chain reaction, J. Med. Virol. 35: 136–141 (1991).
Dunkle, L. M., Arvin, A. M., Whitley, R. J., Rotbart, H. A., Feder, H. M., Feldman, S., Gershon, A. A., Levy, M. L., Hayden, G. E, Mcguirt, P. V., Harris, J., and Balfour, H. H., A controlled trial of acyclovir for chickenpox in normal children, N. Engl. J. Med. 325: 1539–1544 (1991).
Echevarria, J. M., Casas, 1., Tenorio, A., DE Ory, F., and Martinezmartin, P., Detection of varicella-zoster virus-specific Dna sequences in cerebrospinal fluid from patients with acute aseptic meningitis and no cutaneous lesions, J. Med. Virol. 43: 331–335 (1994).
Eckstein, R., Jehn, U., and Loy, A., Endemic chickenpox on a cancer ward, J. Infect. Dis. 149: 829–830 (1984).
Edson, C. M., Hosler, B. A., Respess, R. A., Waters, D. J., and Thorleylawson, D. A., Cross reactivity between herpes simplex virus glycoprotein B and a 63,000 dalton varicella-zoster virus envelope glycoprotein, J. Virol. 56: 333–336 (1985).
Enders, G., Miller, M., Cradock-Watson, J., Bolley, I., and Ridehalgh, M., Consequences of varicella and herpes zoster in pregnancy; prospective study of 1739 cases, Lancet 343: 1547–1550 (1994).
Feder, H. M., Treatment of adult chickenpox with oral acyclovir, Arch. Intern. Med. 150: 2061–2065 (1990).
Feldman, S., Chaudary, S., Ossi, M., and Epp, E. A., A viremic phase for herpes zoster in children with cancer, J. Pediatr. 91: 597–600 (1977).
Feldman, S., Hughes, W. T., and Kim, H. Y., Herpes zoster in children with cancer, Am. J. Dis. Child. 126: 178–184 (1973).
Feldman, S., and Lorr, L., Varicella in children with cancer: Impact of antiviral therapy and prophylaxis, Pediatrics 80: 465–472 (1987).
Fleisher, G., Henry, W., Mcsorley, M., Arbeter, A., and Plotkin, S., Life threatening complications of varicella, Am. J. Dis. Child. 135: 896–899 (1981).
Forghani, B., Schmidt, N. J., and Dennis, J., Antibody assays for varicella-zoster virus: Comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination and complement fixation, J. Clin. Microbiol. 8: 545–552 (1978).
Foung, S. K. H., Perkins, S., Koropchak, C., Fishwild, D. M., Wittek, A. E., Engleman, E. G., Grumet, E. C., and Arvin, A. M, Human monoclonal antibodies neutralizing varicella-zoster virus, J. Infect. Dis. 152: 280–285 (1985).
Frey, H. M., Bialkin, G., and Gershon, A. A., Congenital varicella: Case report of a serologically proved long-term survivor, Pediatrics 59: 110–112 (1977).
Frey, H. M., Steinberg, S. P., and Gershon, A. A., Diagnosis of varicella-zoster infections, in: The Human Herpesviruses. An Interdisciplinary Perspective (A. J. Nahmias, W. R. Dowdle, And R. E Schinazi, Eds.), pp. 351–362, Elsevier, New York, 1981.
Friedman, M. G., Haikin, H., Leventonkriss, S., Joffe, R., Goldstein, V., and Sarov, I., Detection of antibodies to varicella zoster virus by radio-immunoassay and enzyme immunoassay techniques, Med. Microbiol. Immunol. 166: 177–186 (1978).
Furuta, Y., Takasu, Y., Fukuda, S., Satomatsumura, K. C., Inuyama, Y., Hondo, R., and Nagashima, K., Detection of varicella-zoster Dna in human geniculate ganglia by polymerase chain reaction, J. Infect. Dis. 166: 1157–1159 (1992).
Garland, J., Varicella following exposure to herpes zoster, N. Engl. J. Med. 228: 336–337 (1943).
Garnett, G. P., Cox, J. M., Bundy, D. A. P., Didier, J. M., and ST. Catherine, J., The age of infection with varicella-zoster virus in St. Lucia, West Indies, Epidemiol. Infect. 110: 361–372 (1993).
Garnett, G. P., and Grenfell, B. T., The epidemiology of varicella-zoster virus infections: A mathematical model, Epidemiol. Infect. 108: 495–511 (1992).
Garnett, G. P., and Grenfell, B. T., The epidemiology of varicella-zoster infections: The influence of varicella on the prevalence of zoster, Epidemiol. Infect. 108: 513–528 (1992).
Gershon, A. A., Varicella vaccine; still at the cross roads, Pediatrics 90 (Suppl.): 144–148 (1992).
Gershon, A. A., Brunell, P. A., Doyle, E. E, and Clapps, A. A., Steroid therapy and varicella, J. Pediatr. 81: 1034 (1972).
Gershon, A. A., Frey, H. M., Steinberg, S. P., Seeman, M. D., Bidwell, D., and Voller, A., Determination of immunity to varicella using an enzyme-linked-immunosorbent assay, Arch. Virol. 70: 169–172 (1981).
Gershon, A. A., And Krugman, S., Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test, Pediatrics 56: 1005–1008 (1976).
Gershon, A. A., Larussa, P., and Steinberg, S., Detection of antibodies to varicella-zoster virus using a latex agglutination assay, Clin. Diagn. Virol. 2: 271–277 (1994).
Gershon, A. A., Raker, R., Steinberg, S., Topfolstein, B., and Drusin, L. M., Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life, Pediatrics 58: 692–696 (1976).
Gershon, A. A., and Steinberg, S. P., Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections, Infect. Immun. 25: 170–174 (1979).
Gershon, A., Steinberg, S., and Brunell, P. A., Zoster immune globulin: A further assessment, N. Engl. J. Med. 290: 243245 (1974).
Gershon, A. A., Steinberg, S. P, Gelb, L., and The National Institute OF Allergy And Infectious Diseases Collabora- 82. Tive Varicella Vaccine Study Group, Clinical reinfection with varicella-zoster virus, J. Infect. Dis. 149: 137–142 (1984).
Gershon, A. A., Steinberg, S., and Smith, M., Cell-mediated 83. immunity to varicella-zoster virus demonstrated by viral inac- tivation with human leucocytes, Infect. Immun. 13: 1549–1553 (1976).
Gilchrest, B., and Baden, H. P., Photodistribution of viral exanthems, Pediatrics 54: 136–138 (1974).
Gilden, D. H., Beinlich, B. R., Rubinstien, E. M., Stommel, E., Swenson, R., Rubinstein, D., and Mahalingam, R., Varicella-zoster myelitis, an expanding syndrome, Neurology 44: 1818–1823 (1994).
Gilden, D. H., Vafai, A., Shtram, Y., Becker, Y., Devlin, M., and Wellish, M., Varicella-zoster virus Dna in human sensory ganglia, Nature 306: 478–480 (1983).
Glynn, C., Crockford, G., Davaghan, D., Cardno, P., Price, D., and Miller, J, Epidemiology of shingles, J. R. Soc. Med. 83: 617–619 (1990).
Gogos, C. A., Apostolidou, E., Bassaris, H. P., and Vagenakis, A. G., Three cases of varicella thrombophlebitis as a 88. complication of varicella zoster infection, Eur. J. Clin. Microbiol. Infect. Dis. 12: 43–45 (1993).
Gold, E., Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection, N. Engl. J. Med. 274: 181–185 (1966).
Goldberg, R. D., and Sarov, I., Enzyme-linked immunosor- bent assay for detection of antibodies to varicella-zoster virus, Isr. J. Med. Sci. 16: 111–117 (1980).
Gordon, J. E., General considerations of modes of transmission, in: Preventive Medicine in World War II, Vol. IV, Communicable 91. Diseases, p. 27, Department of the Army, Washington, DC, 1958.
Gordon, J. E., Chickenpox: An epidemiological review, Am. J. 91a Med. Sci. 244: 362–389 (1962).
Gray, G. C., Palinkas, L. A., and Kelley, P. W., Increasing incidence of varicella hospitalizations in United States army and navy personnel; are today’s teenagers more susceptible? Should recruits be vaccinated? Pediatrics 86: 867–873 (1990).
Grose, C., Edwards, D. P, Friedrichs, W. E., Weigle, K. A., and McGuumE, W. L., Monoclonal antibodies against three major glycoproteins of varicella-zoster virus, Infect. Immun. 40: 381–388 (1983).
Guess, H. A., Broughton, D. D., Melton, L. J., and Kurland, L. T., Chickenpox hospitalizations among residents of Olmsted County, Minnesota, 1962 through 1981. A population based study, Am. J. Dis. Child. 138: 1055–1057 (1984).
Guess, H. A., Broughton, D. D., Melton, L. J., and Kurland, L. T., Epidemiology of herpes zoster in children and 94. adolescents: A population based study, Pediatrics 76: 512–517 (1985).
Gulick, R. M., Heathchiozzi, M., and Crumpacker, C. S., Varicella-zoster virus disease in patients with human immuno- deficiency virus infection, Arch. Derm. 126: 1086–1088 (1990).
Gustafson, T. L., Lavely, G. B., Brawner, E. R., Hutcheson, R. H., Wright, P. F., and Schaffner, W., An outbreak of airborne nosocomial varicella, Pediatrics 70: 550–556 (1982).
Haake, D. A., Zakowski, P. C. Haake, D. L., and Bryson, Y. J., Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: Retrospective controlled study and review, Rev. Infect. Dis. 12: 788–798 (1990).
Hacham, M., Leventon-Kriss, S., and Sarov, I., Enzymelinked immunosorbent assay for detection of virus-specific IgM antibodies to varicella-zoster virus, Intervirology 13: 214–222 (1980).
Haggerty, R. J., and Eley, R. C., Varicella and cortisone, Pediatrics 18: 160–162 (1956).
Haikin, H., Leventonkriss, S., and Sarov, I., Antibody to varicella-zoster virus-induced membrane antigen; immunoperoxidase assay with air-dried target cells, J. Infect. Dis. 140: 601–604 (1979).
Hayward, A., Levin, M., Wolf, W., Angelova, G., and Gilden, D., Varicella-zoster virus specific immunity after herpes zoster, J. Infect. Dis. 163: 873–875 (1991).
Hellinger, W. C., Bolling, J. P., Smith, T. F., and Campbell, R. J., Varicella-zoster virus retinitis in a patient with Aids-related complex; case report and brief review of the acute retinal necrosis syndrome, Clinical Infect. Dis. 16: 208–212 (1993).
Higa, K., Dan, K., and Manabe, H., Varicella-zoster virus infections during pregnancy: Hypothesis concerning the mechanisms of congenital malformations, Obstet. Gynecol. 69: 214–222 (1987).
Hondo, R., Yogo, Y., Kurata, T., And Aoyama, Y., Genome variation among varicella-zoster isolates derived from different individuals and from the same individuals, Arch. Virol. 93: 1–12 (1987).
Hook, E. B., Orandi, M., Ten Bensel, R. W., Schamber, W. F., and ST. Geme, J. W., J., Familial fatal varicella, J.A.M.A. 206: 305–311 (1968).
Hope-Simpson, R. E., Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps), Lancet 2: 549–554 (1952).
Hopesimpson, R. E., The nature of herpes zoster; a long-term study and a new hypothesis, Proc. R. Soc. Med. 58: 9–20 (1965).
Connor, J. D., Bryson, Y. J., and Balfour, H. H., Effect of oral acyclovir on pain resolution in herpes zoster: A reanalysis, J. Med. Virol. Suppl. 1: 93–96 (1993).
Huse, D. M., Meissner, H. C., Lacey, M. J., and Oster, G., Childhood vaccination against chickenpox: An analysis of benefits and costs, J. Pediatr. 124: 869–874 (1994).
Hyman, R. W., Ecker, J. R., and Tenser, R. B., Varicellazoster virus Rna in human trigeminal ganglia, Lancet 2: 814–816 (1983).
Institute OF Medicine Committee ON Issues And Priorities For New Vaccine Development, Diseases of Importance in the United States, Appendix J: Prospects for immunizing against Herpesvirus varicellae, pp. 313–341, National Academy of Sciences, Washington, DC, 1985.
Jacobson, M. A., Berger, T. O., Fikrig, S., Becherer, P., Moohr, J. W., Stanat, S. C., and Biron, K. K., Acyclovirresistant varicella zoster virus after chronic oral acyclovir therapy in patients with acquired immunodeficiency syndrome (Aids), Ann. Intern. Med. 112: 1187–1191 (1990).
Jordan, G. W., and Merigan, T. C., Cell-mediated immunity to varicella-zoster virus: In vitro lymphocyte responses, J. Infect. Dis. 130: 495–501 (1974).
Josephson, A., and Gombert, M. E., Airborne transmission of nosocomial varicella from localized zoster, J. Infect. Dis. 158: 238–241 (1988).
Jueljensen, B. E., A new look at infectious diseases: Herpes simplex and zoster, Br. Med. J. 1: 406–410 (1973).
Kallander, C. F. R., Gronowitz, J. S., and Oldingstenkvist, E., Rapid diagnosis of varicella-zoster virus infection by detection of viral deoxythymidine kinase in serum and vesicle fluid, J. Clin. Microbiol. 17: 280–287 (1983).
Kapsenberg, J. G., Possible antigenic relationships between varicella-zoster virus and herpes simplex virus, Arch. Ges. Virusforsch. 15: 67–73 (1964).
KAss, E. M., Szaniawski, W. K., Levy, H., Leach, J., Srinivasan, K., and Rives, C., Rickettsialpox in a New York city hospital, 1980 to 1989, N. Engl. J. Med. 331: 1612–1617 (1994).
Kidd, S., OzAki, T., Asada, H., Higashi, K., Kondo, K., Hayakawa, Y., Morishima, T., Takahashi, M., and Yamanishi, K., Detection of varicella-zoster virus (Vzv) Dna in clinical samples from patients with Vzv by the polymerase chain reaction, J. Clin. Microbiol. 29: 76–79 (1991).
Kjersem, H., and Jepsen, S., Varicella among immigrants from the tropics, a health problem, Scand. J. Soc. Med. 18: 171–174 (1990).
Koranda, F. C., Dehmel, E. M., Kahn, G., and Penn, I., Cutaneous complications in immunosuppressed renal homograft recipients, J.A.M.A. 229: 419–424 (1974).
Kundratciz, K., Experimentelle Ubertragung von Herpes Zoster auf den Menschen und die Beziehungen von Herpes zoster zu Varicellen, Monatsschr. Kinderheilkd. 29: 516–522 (1925).
Laforet, E. G., and Lynch, C. L., Multiple congenital defects following maternal varicella. Report of a case, N. Engl. J. Med. 236: 534–537 (1947).
Landry, M. L., And Hsiung, G. D., Diagnosis of dual herpes virus infection: Varicella and herpes simplex viruses, in: The Human Herpesviruses (A. J. Nahmias, W. R. Dowdle, and R. E Schinazi, Eds.), pp. 652–653, Elsevier, New York, 1981.
Larkin, M., Heckels, J. E., and Ogilvie, M. M., Antibody response to varicella-zoster virus surface glycoproteins in chickenpox and shingles, J. Gen. Virol. 66: 1785–1793 (1985).
Leclair, J. M., Zaia, J. A., Levin, M. J., Congdon, R. G., and Goldmann, D. A., Airborne transmission of chickenpox in a hospital, N. Engl. J. Med. 302: 450–453 (1980).
Levin, M. J., Murray, M., Rotbart, H. A., Zerbe, G. O., White, C. J., and Hayward, A. R., Immune response of elderly individuals to live attenuated varicella vaccine, J. Infect. Dis. 166: 253–259 (1992).
Levin, M. J., Leventhal, S., and Masters, H. A., Factors influencing quantitative isolation of varicella virus, J. Clin. Microbiol. 19: 880–883 (1984).
Levin, M. J., Murray, M., Zerbe, G. O., White, C. J., and Hayward, A. R., Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine, J. Infect. Dis. 170: 522–526 (1994).
Lieu, T. A., Cochi, S. L., Halloran, M. E., Shinefield, H. R., Holmes, S. J., Wharton, M., and Washington, A. E., Costeffectiveness of a routine varicella vaccination program for US children, J.A.M.A. 271: 375–381 (1994).
Lipscxirrz, B., Untersuchungen uber die Atiologie der Krankheiten des Herpesgruppe (Herpes zoster, Herpes genitalis, Herpes febrilis), Arch. Dermatol. Syph. Orig. 136: 428–482 (1921).
Lipton, S. V., and Brunell, P. A., Management of varicella exposure in a neonatal intensive care unit, J.A.M.A. 261: 17821784 (1989).
Locksley, R. M., Flournoy, N., Sullivan, K. M., and Meyers, J. D., Infection with varicella-zoster virus after marrow transplantation, J. Infect. Dis. 152: 1172–1181 (1985).
Lokke Jensen, B., Weismann, K., Mathiesen, L., and Klem Thomsen, H., Atypical varicella-zoster infection in Aids, Acta Denn. Venereol. (Stockh.) 73: 123–125 (1993).
London, W. P., and Yorke, J. A., Recurrent outbreaks of measles, chickenpox, and mumps. I. Seasonal variations in contact rates, Am. J. Epidemiol. 98: 453–468 (1972).
Longfield, J. N., Winn, R. E., Gibson, R. L., Juchau, S. V., and Hoffman, P. V., Varicella outbreaks in army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics, Arch. Intern. Med. 150: 970–973 (1990).
Lonnqvist, B., Ljungman, P., Bolme, P., Gahrton, G., Ringden, O., and Wahren, B., Frequency of reactivation of varicella-zoster virus (Vzv) infection with and without symptoms after bone marrow transplantation, Exp. Hematol. 13 (Suppl. 17): 72 (1985).
Luby, J. P., Ramirez-Ronda, C., Rinner, S., Hull, A., and Vergnemarini, P., A longitudinal study of varicella-zoster virus infections in renal transplant recipients, J. Infect. Dis. 135: 659–663 (1970).
Lux, S. E., Johnston, R. B., August, C. S., Say, B., Penchaszadeh, V. B., Rosen, E S., And Mckusick, V. A., Chronic neutropenia and abnormal cellular immunity in cartilage-hair hypoplasia, N. Engl. J. Med. 282: 231–236 (1970).
Lyall, E. G. H., Ogilvie, M. M., Smith, N. M., and Burns, S., Acyclovir-resistant varicella zoster and Hiv infection, Arch. Dis. Child. 70: 133–135 (1994).
Lynfield, R., Herrin, J. T., and Rubin, R. H., Varicella in pediatric renal transplant recipients, Pediatrics 90: 216–220 (1992).
Mahalingam, R., Wellish, M. C., Dueland, A. N., Cohrs, R. J., and Gilden, D. H., Localization of herpes simplex virus and varicella zoster virus Dna in human ganglia, Ann. Neurol. 31: 444–448 (1992).
Manson, M. M., Logan, W. P. D., and Loy, R. M., Rubella and Other Virus Infections during Pregnancy, Report 101, pp. 1–101, Ministry of Health, Her Majesty’s Stationery Office, London, 1960.
Maretic, A., And Cooray, M. P. M., Comparisons between chickenpox in a tropical and a European country, J. Trop. Med. Hyg. 66: 311–315 (1963).
Martin, J. H., Dohner, D. E., Wellinghoff, W. J., and Gelb, L. D., Restriction endonuclease analysis of Varicella-zoster vaccine virus and wild-type Dnas, J. Med. Virol. 9: 69–76 (1982).
Martin, K. A., Junker, A. K., Thomas, E. E., Allen, M. I., and Friedman, J. M., Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus, J. Infect. Dis. 170: 991–995 (1994).
Marwick, C., Lengthy tale of varicella vaccine development finally nears a clinically useful conclusion, J.A.M.A. 273: 833–836 (1995).
Mcgregor, R. M., Herpes zoster, chickenpox and cancer in general practice, Br. Med. J. 1: 84–87 (1957).
Mcgregor, R. S., Zitelli, B J, Urbach, A. H., Malatack, J. J., and Gartner, J. C., Varicella in pediatric orthotopic liver transplant recipients, Pediatrics 83: 256–261 (1989).
McKusicK, V. A., Fatal varicella (letter to the editor), J.A.M.A. 207: 370 (1969).
Meier, J. L., Holman, R. E, Croen, K. D., Smialek, J. E., and Straus, S. E., Varicella-zoster virus transcription in human trigeminal ganglia, Virology 193: 193–200 (1993).
Meszner, Z., Nyerges, G., And Bell, A. R., Oral acyclovir to prevent dissemination of varicella in immunocompromised children, J. Infection 26: 9–15 (1993).
Meurisse, V., Miller, E., and Kensit, J., Varicella in maternity units, Lancet 1: 1100–1101 (1990).
Meyers, J. D., Congenital varicella in term infants; risk reconsidered, J. Infect. Dis. 129: 215–217 (1974).
Miller, A. E., Selective decline in cellular immune response to varicella-zoster in the elderly, Neurology (Minneap.) 30: 582–587 (1980).
Miller, E., Vurdien, J., and Farrington, P., Shift in age in chickenpox, Lancet 1: 308–309 (1993).
Nader, S., Bergen, R., Shari, M., and Arvin, A. M., Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine, J. Infect. Dis. 171: 13–17 (1995).
Nahass, G. T., Goldstein, B. A., Zhu, W. Y., Serfling, U., Penneys, N. S., and Leonardi, C. L., Comparison of Tzanck smear, viral culture, and Dna diagnostic methods in detection of herpes simplex and varicella-zoster infection, J.A.M.A. 268: 2541–2544 (1992).
Naraqui, S., Jackson, G. G., Jonasson, O., and Yamashiroya, H. M., Prospective study of prevalence, incidence, and source of herpes virus infections in patients with renal allografts, J. Infect. Dis. 136: 531–540 (1977).
Nguyen, P., Reynaud, J., Pouzol, P, Munzer, M., Richard, O., and Francis, P., Varicella and thrombotic complications associated with transient protein C and protein S deficiencies in children, Eur. J. Pediatr. 153: 646–649 (1994).
Nyerges, G., MEszNer, Z. Gyarmati, E., and Kerpelfronius, S., Acyclovir prevents dissemination of varicella in immunocompromised children, J. Infect. Dis. 157: 309–311 (1988).
Oberg, G., and Svedmyr, A., Varicelliform eruptions in herpes zoster; some clinical and serological observations, Scand. J. Infect. Dis. 1: 47–49 (1969).
Osler, W., The Principles and Practice of Medicine, p. 65, Appleton, New York, 1892.
Ozaki, T., Ichikawa, T., Matsui, Y., Nagai, T., Asano, Y., Yaminishi, K., And Takahashi, M., Viremic phase in nonimmunocompromised children with varicella, J. Pediatr. 104: 85–87 (1984).
Ozaki, T., Matsui, Y., Asano, Y., Okuno, T., Yamanishi, K., and Takahashi, M., Study of virus isolation from pharyngeal swabs in children with varicella, Am. J. Dis. Child. 143: 1448–1450 (1989).
Ozaki, T., Miwata, H., Matsui, Y., Kid, S., and Yamanishi, K., Varicella-zoster virus Dna in throat swabs, Arch. Dis. Child. 66: 333–334 (1991).
Pahwa, S., Biron, K., Lim, W., Swenson, R, Kaplan, M. H., Sadick, N., and Pahwa, R., Continuous varicella-zoster infection associated with acyclovir resistance in a child with Aids, J.A.M.A. 260: 2879–2882 (1988).
Pallett, A., and Nicholls, M. W. N., Varicella-zoster. Reactivation or reinfection?, Lancet 1: 160 (1986).
Paryani, S. G., and Arvin, A. M., Intrauterine infection with varicella-zoster virus after maternal varicella, N. Engl. J. Med 314: 1542–1546 (1986).
Paryani, S. G., Arvin, A. M., Koropchak, C. M., Wrl l’EK, A. E., Amylon, M. D., Dobkin, M. B., And Budinger, M. D., Comparison of varicella-zoster antibody titers in patients given intravenous immune serum globulin or varicella-zoster immune globulin, J. Pediatr. 105: 200–205 (1984).
Pastuszak, A. L., Levy, M., Schick, B., Zuber, C., Feldcamp, M., Gladstone, J., Barlevy, F., Jackson, E., Donnenfeld, A., Meshing, W., and Karen, G., Outcome after maternal varicella in the first 20 weeks of pregnancy, N. Engl. J. Med. 330: 901–905 (1994).
Perronne, C., Lazanas, M., Leport, C., Simon, F., Salmon, D., Dallot, A., and Vilde, J.-L., Varicella in patients infected with the human immunodeficiency virus, Arch. Dernurtol. 126: 1033–1036 (1990).
Pons, J.-C., Rozenberg, E, Imbert, M.-C., Lebron, P., Olivennes, R, Lelaidier, C., Straub, N., Vial, M.; and Frydman, R., Prenatal diagnosis of second-trimester congenital varicella syndrome, Prenat. Diagn. 12: 975–976 (1992).
Preblud, S. R., Age-specific risks of varicella complications, Pediatrics 68: 14–17 (1981).
Preblud, S. R., Cochi, S. L., and Orenstein, W. A., Letter to the editor, N. Engl. J. Med. 315: 1416–1417 (1986).
Preblud, S. R., and Dangelo, L. J., Chickenpox in the United States, 1972–1977, J. Infect. Dis. 140: 257–260 (1979).
Ragozzino, M. W., Melton, L. J., Iii, Kurland, L. T., Chu, C. P., and Perry, H. O., Population-based study of herpes zoster and its sequelae, Medicine 61: 310–316 (1982).
Rasmussen, L., Holmes, A. R., Hofmeister, R., and Merigan, T., Multiplicity-dependent replication of varicella-zoster virus in interferon treated cells, J. Gen. V irol. 35: 361–368 (1977).
Rifkind, D., The activation of varicella-zoster virus infections by immunosuppressive therapy, J. Lab. Clin. Med. 68: 463–474 (1966).
Roberts, G. B., Fyfe, J. A., Gaillard, R. K., and Short, S. A., Mutant varicella-zoster thymidine kinase; correlation of clinical resistance and enzyme impairment, J. V irol. 65: 6407–6413 (1991).
Ross, A. H., Modification of chickenpox in family contacts by administration of gamma globulin, N. Engl. J. Med 267: 369–376 (1962).
Ross, C. A. C., Subak Sharpe, J. H., And Ferry, E, Antigenic relationship of varicella-zoster and herpes simplex, Lancet 2: 708–711 (1965).
Ruckdeschel, J. C., Schimpff, S. C., Smyth, A. C., and Mardiney, M. R., Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin’s disease, Am. J. Med. 62: 77–85 (1977).
Sabin, A. B., Neurotropic virus diseases of man, J. Pediatr. 19: 445–451 (1941).
Salomon, J. B., Gordon, J. E., And Scrimshaw, N. S., Studies of diarrheal disease in Central America. X. Associated chickenpox, diarrhea and kwashiorkor in a highland Guatemalan village, Am. J. Trop. Med. 15: 997–1002 (1966).
Schaap, G. J. P., And Huisman, J., Simultaneous rise in complement fixing antibodies against herpesvirus hominis and varicellazoster virus, Arch. Ges. Virusforsch. 17: 495–503 (1968).
Schmader, K., George, L. K., Burchett, B. M., Pieper, C. F., and Hamilton, J. D., Racial differences in the occurence of zoster, J. Infect. Dis. 171: 701–704 (1995).
Schmidt, N. J., Lennette, E. H., and Magoffin, R. L., Immunologic relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization, and fluorescent antibody tests, J. Gen. V irol. 4: 321–328 (1969).
School Epidemics Committee OF Great Britain, Epidemics in Schools, Medical Research Council, Special Report Series No. 227, London, His Majesty’s Stationery Office, 1938.
Selby, P. J., Powles, R. L., Jameson, B., Kay, H. E. M., Watson, J. G., Thornton, R., Morgenstern, G., Clink, H. M., McElwain, T. J., Prentice, H. G., Corrigham, R., Ross, M. G., Hoffbrand, A. V., and Brigden, D., Parenteral acyclovir therapy for herpesvirus infection in man, Lancet 2: 1267–1270 (1979).
Shanley, J., Myers, M., Edmond, B., and Steele, R, Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus, J. Clin. Microbiol. 15: 208–211 (1982).
Shehab, Z., and Brunell, P. A., Enzyme-linked immunosorbent assay for susceptibility to varicella, J. Infect. Dis. 148: 472476 (1983).
Siegel, M., Congenital malformations following chickenpox, measles, mumps, and hepatitis: Results of a cohort study, J.A.M.A. 226: 1521–1524 (1973).
Siegel, M., and Fuerst, H. T., Low birth weight and maternal virus disease: A prospective study of rubella, measles, mumps, chickenpox, and hepatitis, J.A.M.A. 197: 680–684 (1966).
Sinha, D. P., Chickenpox-a disease predominantly affecting adults in West Bengal, India, Int. J. Epidemiol. 5: 367–374 (1976).
Smith, G. R., Mckenzie, J. M., Marmer, D. J., and Steele, R W., Psychologic modulation of the human immune response to varicella zoster, Arch. Intern. Med. 145: 2110–2112 (1985).
Soriano, V., Bru, F., and Gonzalezlahos, J., Fatal varicella hepatitis in a patient with Aids, J. Infect. 25: 107 (1992).
Steiner, Zur Inokulation der Varicellen., Wien. Med. Wochenschr. 25: 306 (1875).
Stevens, D. A., Ferrington, R. A., Jordan, G. W., and Merigan, T. C., Cellular events in zoster vesicles; relation to clinical course and immune parameters, J. Infect. Dis. 131: 509–515 (1975).
SToKEs, J., JR., Chickenpox, in: Preventive Medicine in World War II, Vol. IV, Communicable Diseases, Transmitted Chiefly Through Respiratory and Alimentary Tracts, (E. C. Hoff and R. M. Hoff, Eds.), pp. 55–56, Department of Army, Washington, DC, 1958.
Straus, S. E., Shingles; sorrows, salves, solutions, J.A.M.A. 269: 1836–1839 (1993).
Straus, S. E., Overview: The biology of varicella-zoster virus infection, Ann. Neurol. Suppl. 35: 4–8 (1994).
Straus, S. E., Hay, J., Smith, H., and Owens, J., Genome differences among varicella-zoster virus isolates, J. Gen. V irol. 64: 1031–1041 (1983).
Straus, S. E., Reinhold, W., Smith, H. A., Ruyechan, W. T., Henderson, D. K., Blaese, R. M., and Hay, J., Endonuclease analysis of viral Dna from varicella and subsequent zoster infections in the same patient, N. Engl. J. Med. 311: 1362–1364 (1984).
Strom, J., Social development and declining incidence of some common epidemic diseases in children; a study of the incidence in different age groups in Stockholm, Acta Paediatr. Scand. 56: 159–163 (1967).
Takahashi, M., Current status and prospects of live varicella vaccine, Vaccine 10: 1007–1014 (1992).
Takahashi, M., Okuno, Y., Otsuka, T., Osame, J., Takamizawa, A., Sasudo, T., and Kuso, T., Development of a live attenuated varicella vaccine, Biken J. 18: 25–33 (1975).
Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., Yazaki, T., and Isomura, S., Live vaccine used to prevent the spread of varicella in children in hospital, Lancet 2: 1288–1290 (1974).
Talbot, G. H., Skros, M., Fisher, M., and Friedman, H., Immunologic evidence of reinfection with varicella-zoster virus, J. Infect. Dis. 149: 1035–1036 (1984).
Terada, K., Kawano, S., Yoshihiro, A., Miyashima, H., and Morita, T., Characteristics of herpes zoster in otherwise normal children, Pediatr. Infect. Dis. J. 12: 960–961 (1993).
Tyzzer, E. E., The histology of the skin lesions in varicella, Philipp. J. Sci. 1: 349–372 (1906).
Uduman, S. A., Gershon, A. A., and Brunell, P. A., Rapid diagnosis of varicella-zoster by agar-gel diffusion, J. Infect. Dis. 126: 193–195 (1972).
Verroust, E, Lemay, D., and Laurian, Y., High frequency of herpes zoster in young hemophiliacs, N. Engl. J. Med. 316: 166–167 (1987).
Virolainen, M., Savilahiti, E., Katila, I., and Perhentupa, J., Cellular and humoral immunity in cartilage-cell hypoplasia, Pediatr. Res. 12: 961–966 (1978).
Von Bokay, J., Uber den aetiologischen Zussammenhang der Varicellen mit gewissen Fallen von Herpes zoster, Wien. Klin. Wochenschr. 22: 1323–1326 (1909).
Wade, N. A., Lepow, M. L., Veazey, J., and Meuwissen, H. J., Progressive varicella in three patients with Wiskott-Aldrich syndrome; treatment with adenine anabinoside, Pediatrics 75: 672–675 (1985).
Wallace, M. R., Bowler, W. A., Murray, N. B., Brodine, S. K., and Oldfield, E. C., Iii, Treatment of adult varicella with oral acyclovir. A randomized, placebo-controlled trial, Ann. Intern. Med. 117: 358–363 (1992).
Waner, J. L., and Weller, T. H., Varicella-zoster virus, in: Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections, 6th ed. (N. J. Schmidt And R. W. Emmons, Eds.), pp. 379–406, American Public Health Association, Washington, DC, 1979.
Watson, B., Boardman, C., Laufer, S., Piercy, S., Tustin, N., Olaleye, D., Cnaan, A., and Starr, S. E., Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine, Clin. Infect. Dis. 20: 316–319 (1995).
Weber, D. M., and Pellecchia, J. A., Varicella pneumonia; study of prevalence in adult men, J.A.M.A. 192: 572–573 (1965).
Weber, D. J., Rutala, W. A., and Parham, C., Impact and costs of varicella prevention in a university hospital, Am. J. Public Health 78: 19–23 (1988).
Weigle, K. A., and Grose, C., Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation, J. Infect. Dis. 149: 741–749 (1948).
Weller, T. H., The propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster, Proc. Soc. Exp. Biol. Med. 83: 340–346 (1953).
Weller, T. H., Varicella and herpes zoster; a perspective and overview, J. Infect. Dis. 166 (Suppl. 1): S1–6 (1992).
Weller, T H, Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not so benign virus, N. Engl. J. Med. 309: 1362–1368 (1983).
Weller, T. H., and Coons, A. H., Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro, Proc. Soc. Exp. Biol. Med. 86: 789–794 (1954).
Weller, T. H., and Stoddard, M. B., Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid, J. Immunol. 68: 311–319 (1952).
Weller, T. H., and Witton, H. M., The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro, J. Exp. Med. 108: 869–890 (1958).
Weller, T. H., Witon, H. M., and Bell, E. J., The etiologic agents of varicella and herpes zoster; isolation, propagation, and cultural characteristics in vitro, J. Exp. Med. 108: 843–868 (1958).
Wells, M. W., and Holla, W. A., Ventilation in the flow of measles and chickenpox through a community, J.A.M.A. 142: 1337–1344 (1950).
White, E., Chickenpox in Kerala, India, Indian J. Public Health 22: 141–151 (1950).
White, R. J., Simmons, L., and Wilson, R. B., Chickenpox in young anthropoid apes; clinical and laboratory findings, J. Am. Vet. Med. Assoc. 161: 690–692 (1972).
W.H.O. Meeting, Diagnosis of human herpesviruses: Memorandum from a W.H.O. meeting, Bull. World Health Organ. 69: 277–283 (1991).
Whitley, R. J., and Gnann, J. W., Acyclovir: A decade later, N. Engl. J. Med 327: 782–789 (1992).
Whitley, R. J., Gnann, J. W., Hinthorn, D., Liu, C., Pollard, R. B., Hayden, F., Mertz, G. J., Oxman, M., Soong, S.-J., and The Niaid Collaborative Antiviral Study Group, Disseminated herpes zoster in the immunocompromised host: A comparative trial of acyclovir and vidarabine, J. Infect. Dis. 165: 450–455 (1992).
Williams, V., Gershon, A., and Brunell, P. A., Serologic response to varicella-zoster membrane antigens measured by indirect immunofluorescence, J. Infect. Dis. 130: 669–672 (1974).
Wilson, A., Sharp, M., Koropchak, C. M., Ting, S. F., and Arvin, A. M., Subclinical varicella-zoster viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster antigens after bone marrow transplantation, J. Infect. Dis. 165: 119–126 (1992).
Wifson, D., Bressani, R., and Scrimshaw, N. S., Infection and nutritional status. I. Effect of chickenpox on nitrogen metabolism in children, Am. J. Clin. Nutr. 9: 154–158 (1961).
Winsnes, R., Efficacy of zoster immunoglobulin in prophylaxis of varicella in high-risk patients, Acta Paediatr. Scand. 67: 7782 (1978).
WreghrTT, T. G., Tedder, R. S., Naginton, J., and Ferns, R. B., Antibody assays for varicella virus: Comparison of competitive enzyme-linked immunosorbent assay (Elisa), competitive radioimmunoassay (Ria), complement fixation, and indirect fluorescence assays, J. Med. Viral. 13: 361–370 (1984).
Yorke, J. A., and London, W. P., Recurrent outbreaks of measles, chickenpox, and mumps. H. Systematic differences in contact rates and stochastic effects, Am. J. Epidemiol. 98: 469–482 (1973).
Zaia, J. A., Leary, P. L., and Levin, M. J., Specificity of the blastogenic response of human mononuclear cells to herpesvirus antigens, Infect. Immun. 20: 646–651 (1978).
Zaia, J. A., Levin, M. J., Preblud, S. R., Leszczynski, J., Wright, G. G., Ellis, R. J., Curtis, A. C., Valerio, M. A., and LE Gore, J., Evaluation of varicella-zoster immune globulin: Protection of immunosuppressed children after household exposure to varicella, J. Infect. Dis. 147: 737–743 (1983).
Zaia, J. A., Levin, M. J., Wright, G. G., and Grady, G. F., A practical method for preparation of varicella-zoster immune globulin, J. Infect. Dis. 137: 601–604 (1978).
Zaia, J. A., and Oxman, M. N., Antibody to varicella-zoster virus-induced membrane antigen: Immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells, J. Infect. Dis. 136: 519–530 (1977).
Ziegler, T., Detection of varicella-zoster viral antigens in clinical specimens by solid phase enzyme immunoassay, J. Infect. Dis. 150: 149–154 (1984).
Zinsser, H., Immunology of infections by filterable virus agents, in: Virus and Rickettsial Diseases, pp. 89–117, Harvard University Press, Cambridge, 1940.
Suggested Reading
Gordon, J. E., Chickenpox: An epidemiological review, Am. J. Med. Sci. 244: 362–389 (1962).
Gelb, L. D., Varicella-zoster virus, in: Virology, 2nd ed. (B N Fields and D. M. Knipe, Eds.), pp. 2011–2054, Raven Press, New York, 1990.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Weller, T.H. (1997). Varicella—Herpes Zoster Virus. In: Evans, A.S., Kaslow, R.A. (eds) Viral Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0036-4_29
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0036-4_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-44856-0
Online ISBN: 978-1-4899-0036-4
eBook Packages: Springer Book Archive